Keyphrases
Coronary Artery Disease
87%
Bezafibrate
82%
Infarction
61%
Hazard Ratio
50%
Confidence Interval
49%
Heart Failure
38%
Coronary Patients
38%
C-reactive Protein
36%
Plasma Fibrinogen
35%
Fibrinogen
34%
Patients with Coronary Artery Disease
33%
High-density Lipoprotein Cholesterol (HDL-C)
31%
Prevention Studies
30%
Ischemic Stroke
28%
Triglycerides
27%
Lipoproteins
27%
Meta-analysis
26%
Population-based Study
23%
Myocardial Infarction
22%
C-reactive Protein Level
21%
Secondary Prevention
20%
Israeli
20%
Adult Congenital Heart Disease
20%
Israel
19%
Individual Participant Meta-analysis
17%
Body Mass Index
16%
Low-density Lipoprotein Cholesterol (LDL-C)
15%
Non-vascular
15%
LDL Cholesterol
15%
Cardiovascular Disease
14%
Epidemiological Study
14%
Lipids
14%
Cholesterol
13%
Cardiovascular Events
13%
Long-term Prognosis
13%
Prevention Trials
13%
Chronic Coronary Heart Disease
13%
Diabetes
13%
Disease Management
13%
Adjusted Hazard Ratio
13%
Beta-blockers
13%
Increased Mortality
13%
Stable Coronary Artery Disease
13%
Recurrent Coronary Events
12%
Insulin Resistance
12%
Risk Factors
12%
Individual Participant Data
12%
Triglyceride Level
11%
Cardiovascular Risk
11%
Coronary Disease
11%
Pharmacology, Toxicology and Pharmaceutical Science
Ischemic Heart Disease
100%
Bezafibrate
64%
Coronary Artery Disease
54%
Infarction
44%
Heart Failure
36%
Heart Infarction
34%
High Density Lipoprotein Cholesterol
34%
C Reactive Protein
32%
Triacylglycerol
27%
Brain Ischemia
25%
Diabetes Mellitus
22%
Fibrinogen
22%
Disease
19%
Congenital Heart Disease
17%
Prospective Study
16%
Lipoprotein
15%
Cardiovascular Disease
13%
Acute Coronary Syndrome
13%
Apolipoprotein
13%
Insulin Resistance
12%
Beta Adrenergic Receptor Blocking Agent
11%
Adiponectin
11%
Metformin
11%
Mortality Rate
11%
Low Density Lipoprotein Cholesterol
11%
Inflammation
10%
Fibric Acid Derivative
10%
Placebo
10%
Prevalence
9%
Metabolic Syndrome X
9%
Vascular Disease
9%
Acute Heart Infarction
8%
Peroxisome Proliferator Activated Receptor
7%
Non Insulin Dependent Diabetes Mellitus
7%
Antidiabetic Agent
7%
Lipoprotein A
6%
Angina Pectoris
6%
All Cause Mortality
6%
Chronic Kidney Failure
6%
Randomized Controlled Trial
6%
Morbidity
6%
Kidney Disease
6%
Sulfonylurea
6%
1 Alkyl 2 Acetylglycerophosphocholine Esterase
5%
CD40 Ligand
5%
Hyperglycemia
5%
Acetylsalicylic Acid
5%
Fenofibrate
5%
Anemia
5%
ST Segment Elevation Myocardial Infarction
5%
Medicine and Dentistry
Ischemic Heart Disease
50%
Hazard Ratio
35%
Heart Failure
30%
Apoplexy
29%
Diabetes Mellitus
25%
Coronary Artery Disease
25%
Meta-Analysis
24%
Infarction
22%
Myocardial Infarction
20%
Bezafibrate
20%
Persistent Truncus Arteriosus
17%
Brain Ischemia
17%
Diabetes
15%
Prevalence
14%
Disease
13%
Pulmonary Artery
11%
Lung Artery Pressure
11%
Disease Management
11%
Lipoprotein
11%
Systolic Blood Pressure
11%
Glycon
11%
Socioeconomic Status
11%
Acute Coronary Syndrome
11%
Maturity Onset Diabetes of the Young
11%
Body Mass Index
11%
Secondary Prevention
10%
Metabolic Syndrome
9%
Dyslipidemia
8%
Fibrinogen
8%
High Density Lipoprotein Cholesterol
7%
C Reactive Protein
7%
ST Elevation
7%
Cardiovascular Disease
7%
Mortality Rate
7%
Kidney Function
7%
Prospective Study
6%
Cardiology
6%
Antidiabetic Agent
6%
Health Outcomes
6%
Patient-Data
6%
Morbidity
6%
Population Research
6%
Insulin Resistance
6%
Sulfonylurea
6%
Primary Health Care
6%
Access to Health Care
5%
Hyperglycemia
5%
Anemia
5%
Cerebellum
5%
Brainstem
5%
